AMGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.22 BRL | -1.87% |
|
-1.31% | +14.55% |
| Jun. 14 | Amgen Gets FDA Approval to Treat Aggressive Leukemia Type with Blincyto | DJ |
| Jun. 14 | Amgen Says FDA Approves Blincyto to Treat Type of Blood Cancer | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 791B | ||||||
| 630B | ||||||
| 350B | - | - | - | - | ||
| 328B | ||||||
| 298B |
